Healthcare Stocks Today
These are the healthcare stocks leading on relative strength in our latest scan — pharma, biotech, medical devices, and managed care, ranked by RS Rating.
Healthcare heatmap
Full market map →Each tile is a healthcare name, sized by market capitalization and colored by the day's move (saturating at ±5%). Click any tile for its full dossier.
| # | Symbol | Price | Change | RS | RVol | RSI |
|---|---|---|---|---|---|---|
| 1 | AGL52w | $118.41 | +10.41% | 99 | 1.25× | 69 |
| 2 | VOR | $16.21 | +8.57% | 99 | 7.58× | 61 |
| 3 | SPRC | $6.12 | +4.35% | 99 | 0.01× | 42 |
| 4 | ERNA | $6.99 | -5.54% | 99 | 349.26× | 50 |
| 5 | CUPR | $5.32 | -5.84% | 99 | 0.00× | 61 |
| 6 | AKAN | $13.90 | -6.59% | 99 | 0.04× | 42 |
| 7 | ICCM | $5.89 | -16.10% | 99 | 0.02× | 59 |
| 8 | ABVX | $97.40 | +5.45% | 98 | 0.43× | 44 |
| 9 | STRO | $30.55 | +3.37% | 98 | 1.62× | 53 |
| 10 | ANRO | $27.07 | +7.00% | 97 | 3.40× | 71 |
| 11 | ABSI52w | $10.88 | +6.56% | 97 | 2.31× | 75 |
| 12 | QURE | $47.62 | -3.02% | 97 | 2.32× | 74 |
| 13 | SLS52w | $12.37 | +17.47% | 96 | 3.17× | 79 |
| 14 | CMPS52w | $14.82 | +9.13% | 96 | 3.27× | 71 |
| 15 | QTTB | $13.01 | +8.87% | 96 | 1.27× | 60 |
+ 416 more Healthcare names — plus the chart, levels, and trade plan for each
Free accounts unlock the cockpit chart and dossier on every name above. Pro adds the full ~12,300-symbol screener — filter this sector by RS, RSI, volume, and more — plus real-time intraday alerts.
Start free — 7-day full access →RS = RS Rating, a 1–99 relative-strength percentile vs. the whole market. RVol = relative volume vs. the stock's recent average. RSI = 14-day Relative Strength Index. Limited to liquid names (≥ $5M traded per day, above $5) to keep the list tradeable. Educational data, not financial advice.
About healthcare stocks today
Healthcare is a split-personality sector. Large-cap pharma, device makers, and insurers are defensive — demand for medicine doesn't track the economic cycle, so the group often holds up when growth wobbles. Biotech, on the other hand, is among the most speculative corners of the market: small companies that can double or halve on a single trial readout or FDA decision.
That mix makes a relative-strength screen especially useful here. It surfaces the defensive large caps quietly trending higher in a risk-off tape and the biotech names catching a bid ahead of (or after) a catalyst — two very different setups that both show up as strength versus the market. Biotech moves are binary and fast, so position sizing matters more in that part of the list.
Every evening after the close, StockSetups scans the full US equities universe (~12,300 stocks and ETFs), tags each by sector, and scores its relative strength. This page lists that sector's names from the latest scan, ranked by RS Rating — an IBD-style 1–99 percentile of how each stock's price performance compares to the entire market — so the leaders sit on top. We limit the list to liquid, tradeable names (at least $5M traded a day and a share price above $5) so it isn't cluttered with illiquid micro-caps.
Frequently asked questions
What stocks are in the healthcare sector?
Healthcare spans pharmaceuticals, biotechnology, medical devices and equipment, life-science tools, healthcare providers, and managed-care insurers — from defensive mega-caps to speculative clinical-stage biotechs.
Is healthcare a defensive sector?
Large-cap pharma, devices, and insurers are defensive — demand is relatively independent of the economic cycle. Biotech is the exception: it's high-risk and catalyst-driven, behaving more like speculative growth than a defensive holding.
How often is this updated?
The list refreshes every evening after the US close, once that day's market-wide scan finishes.